» Articles » PMID: 7632812

Thrombotic Thrombocytopenic Purpura/hemolytic Uremic Syndrome: a Multivariate Analysis of Factors Predicting the Response to Plasma Exchange

Overview
Journal Ann Hematol
Specialty Hematology
Date 1995 Jun 1
PMID 7632812
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate pretreatment prognostic factors that could be useful in predicting the response to plasma exchange in thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS). Thirty-two patients with TTP/HUS, treated with plasma exchange at our institution from 1980 to 1994, were studied. The main clinical and laboratory data at the beginning of plasma exchanges were analyzed by the Cox stepwise logistic regression, applied to either treatment failure or death. Seventeen (53%) patients attained a complete remission and 22 (69%) survived (five in advanced renal failure and long-term hemodialysis). Longer delay in initiating plasma exchanges, presence of stupor or coma, and higher creatinine levels at the beginning of plasma exchanges were independent predictors of treatment failure. Stupor or coma at the beginning of plasma exchanges was the only predictor of mortality from unremitted TTP/HUS. Hemoglobin levels, platelet count, and LDH activity, traditionally envisaged as markers of disease activity, neither correlated with previous duration of TTP/HUS nor had any prognostic value. Early diagnosis of TTP/HUS and prompt initiation of intensive plasma exchange emerged from this study as the most effective interventions for improving the prognosis of TTP/HUS patients.

Citing Articles

How We Interpret Thrombosis with Thrombocytopenia Syndrome?.

Yamada S, Asakura H Int J Mol Sci. 2024; 25(9).

PMID: 38732176 PMC: 11084439. DOI: 10.3390/ijms25094956.


A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura.

Abou-Ismail M, Zhang C, Presson A, Chaturvedi S, Antun A, Farland A Res Pract Thromb Haemost. 2024; 8(3):102388.

PMID: 38651093 PMC: 11033197. DOI: 10.1016/j.rpth.2024.102388.


Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023.

Matsumoto M, Miyakawa Y, Kokame K, Ueda Y, Wada H, Higasa S Int J Hematol. 2023; 118(5):529-546.

PMID: 37689812 PMC: 10615956. DOI: 10.1007/s12185-023-03657-0.


Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.

Kubo M, Matsumoto M Int J Hematol. 2023; 117(3):331-340.

PMID: 36757521 DOI: 10.1007/s12185-023-03552-8.


Systemic Lupus Erythematosus Presenting With Thrombotic Thrombocytopenic Purpura at Onset: A Case Report.

Takagi Y, Kobayashi Y, Hirakata A, Takei M, Ogasawara S, Yajima C Front Pediatr. 2022; 10:931669.

PMID: 35979405 PMC: 9376367. DOI: 10.3389/fped.2022.931669.


References
1.
Henon P . [Treatment of thrombotic thrombopenic purpura. Results of a multicenter randomized clinical study]. Presse Med. 1991; 20(36):1761-7. View

2.
Remuzzi G . HUS and TTP: variable expression of a single entity. Kidney Int. 1987; 32(2):292-308. DOI: 10.1038/ki.1987.206. View

3.
Moake J, McPherson P . Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med. 1989; 87(3N):9N-15N. View

4.
Remuzzi G, Zoja C, Rossi E . Prostacyclin in thrombotic microangiopathy. Semin Hematol. 1987; 24(2):110-8. View

5.
Byrnes J, Moake J, Klug P, Periman P . Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol. 1990; 34(3):169-74. DOI: 10.1002/ajh.2830340303. View